RE:Clear, concise and well worth a second read! Bravo AP ! Keep quoting your alter alias.
Show me the sales numbers if they're so unique and revolutionary. Presumably there'd be incalls for purchases flooding in. Haven't seen that reflected in the financial statements yet. All I see is FDA approvals and a consistent quarterly loss with negligible earnings, moving timelines, stagnated growth and a declining share price. Tell me what to be excited.
You guys said the stock would be at the moon last January after DIMI got approved?
Where's the price hike?
I rememeber MM saying, imminent!!
SouthernTierTom wrote: What does pizza sauce or money losing pizza restaurants have to do with Dialco? We have 2 FDA approvals for very unique machines (have a look at the presentations on the Spectral site). We are moving towards getting DIMI approved for home use. As for the share issue they drove the price from around $0.80 per share to do the issue at $.60 per share. Since then someone is manipulating the price well below the $0.60. If you have evidence the institutions that bought are selling please share. I doubt they are.
Paradigm gave Dialco a value of $150 mill in February before the last FDA approval of DIMI. That's $0.60 per share Spectral share for Dialco on it's own before the approval. Outset Medical is worth $2 billion USD and their Tablo machines arguably are not as versatile as Dialco's machines. On an equivalent basis Dialco would be worth $10 Cdn per Spectral share. Similarly look at NxStage. The recent conference and COVID suggest that approved CRRT's are valuable and there's a CRRT shortage. So we have the goods. You decide where your opinion on Dialco's value is. I know where mine is.
Our management is not doing anything (on the surface anyway) to sell machines or promote Dialco. I think all shareholders share that opinion. So on Dec 4 grill them about their lack of effort.